Universal admission laboratory screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) asymptomatic infection across a large health system.

Autor: Cihlar JL; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Harris BD; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Wright PW; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Humphries RM; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee., Taylor CK; Department of Enterprise Analytics, Vanderbilt University School of Medicine, Nashville, Tennessee., Cherry BR; Department of Enterprise Analytics, Vanderbilt University School of Medicine, Nashville, Tennessee., Talbot TR; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2023 Jan; Vol. 44 (1), pp. 68-74. Date of Electronic Publication: 2022 Dec 19.